Skip to main
IQV
IQV logo

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 47%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings has demonstrated strong year-over-year growth in its Functional Service Provider (FSP), Real World Evidence (RWE), and Contract Sales and Marketing Services (CSMS) segments, indicating robust demand across its service offerings. The company reported improved client decision timelines and a strong pipeline, driven by recent drug launches, which underlines positive momentum in its commercial business. Additionally, the improvement in the pricing environment and significant enhancement in the win rate, particularly in the Engagement and Business Performance (EBP) segment, reinforce the confidence in achieving a compound growth rate exceeding 4% on a constant currency basis, excluding COVID-19 impacts.

Bears say

The analysis indicates a negative outlook for IQVIA Holdings based on declining year-over-year revenue growth, which has decreased to 3.8% from 6.8% in the prior quarter, suggesting potential challenges in maintaining robust performance amid tough year-over-year comparisons. The company has expressed that it would be disappointed with revenue growth falling below 5% in 2026, which raises concerns about its ability to meet investor expectations amidst a backdrop of possible slowdown in Real-World Evidence (RWE) growth and reduced hiring due to attrition. Additionally, external factors such as rising interest rates may exert further downward pressure on earnings, compounding the concerns regarding operational productivity and margin impacts from passthroughs.

IQVIA Hlds (IQV) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 47% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 17 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Nov 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $241.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $241.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.